The therapeutic implications of the genomic analysis of malignant pleural mesothelioma.
Where this comes from
- Record sourced from PubMed, PMID 33753750.
- Also identified by DOI 10.1038/s41467-021-22142-y and PMC identifier 7985484.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Delineation of the genomic complexities of malignant pleural mesothelioma (MPM) has lagged behind other malignancies. Zhang et al. meaningfully add to our understanding of MPM, and their findings emphasize the need to combine drug development efforts with appropriate predictive biomarkers.
Medical subject headings
- Antineoplastic Combined Chemotherapy Protocols
- Genomics
- Lung Neoplasms
- Mesothelioma
- Pleural Neoplasms